CliffBio
biologic

Ixinity

Coagulation Factor IX (Recombinant)

Loss of exclusivity—loss of exclusivity
CompanyMedexus Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameIxinity
Active ingredientCoagulation Factor IX (Recombinant)
Strength1000IU
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
Marketing statusRx

More from Medexus Pharma

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.